BACKGROUND AND PURPOSE: Echolucent carotid plaques have been associated with increased risk for stroke. Histological studies suggested that echolucent plaques are hemorrhage- and lipid-rich, whereas echogenic plaques are characterized by fibrosis and calcification. This is the first study to relate echogenicity to plaque composition analyzed biochemically. METHODS: Echogenicity of human carotid plaques was analyzed by standardized high-definition ultrasound and classified into echolucent, with gray-scale median (GSM) <32 and echogenic with GSM > or =32. The biochemical composition of the plaques was assessed by fast-performance liquid chromotography and high-performance thin-layer chromotography. RESULTS: As assessed biochemically (milligrams per gram [mg/g]), echolucent plaques contained less hydroxyapatite (43.8 [SD 41.2] mg/g versus 121.6 [SD 106.2] mg/g; P=0.018), more total elastin (1.7 [SD 0.4] mg/g versus 1.2 [SD 0.4] mg/g; P=0.008), and more intermediate-size elastin forms (1.2 [SD 0.3] mg/g versus 0.8 [SD 0.4] mg/g; P=0.018). There was no difference in collagen amount between echogenic and echolucent plaques, neither biochemically (15.3 [SD 3.7] mg/g versus 14.4 [SD 3.4] mg/g) nor histologically (13.4 [SD 4.9] % versus 13.0 [SD 5.6] %). Cholesterol esters, unesterified cholesterol, and triglycerides were increased in plaques associated with symptoms (22.5 [SD 23.3] mg/g versus 13.3 [SD 3.2]; P=0.04), but no differences were detected between echolucent and echogenic plaques (13.5 [SD 4.0] versus 20.2 [SD 21.5] mg/g). Similar results were obtained by Oil Red O staining (symptomatic 7.6 [SD 4.7] % versus asymptomatic 4.2 [SD 3.6] %; P=0.03; echolucent 5.9 [SD 4.1] % versus echogenic 5.0 [SD 4.0] % of area). CONCLUSIONS: Echogenicity of carotid plaques is mainly determined by their elastin and calcium but not collagen or lipid content. In addition, echolucency is associated to higher elastin content.
BACKGROUND AND PURPOSE: Echolucent carotid plaques have been associated with increased risk for stroke. Histological studies suggested that echolucent plaques are hemorrhage- and lipid-rich, whereas echogenic plaques are characterized by fibrosis and calcification. This is the first study to relate echogenicity to plaque composition analyzed biochemically. METHODS: Echogenicity of human carotid plaques was analyzed by standardized high-definition ultrasound and classified into echolucent, with gray-scale median (GSM) <32 and echogenic with GSM > or =32. The biochemical composition of the plaques was assessed by fast-performance liquid chromotography and high-performance thin-layer chromotography. RESULTS: As assessed biochemically (milligrams per gram [mg/g]), echolucent plaques contained less hydroxyapatite (43.8 [SD 41.2] mg/g versus 121.6 [SD 106.2] mg/g; P=0.018), more total elastin (1.7 [SD 0.4] mg/g versus 1.2 [SD 0.4] mg/g; P=0.008), and more intermediate-size elastin forms (1.2 [SD 0.3] mg/g versus 0.8 [SD 0.4] mg/g; P=0.018). There was no difference in collagen amount between echogenic and echolucent plaques, neither biochemically (15.3 [SD 3.7] mg/g versus 14.4 [SD 3.4] mg/g) nor histologically (13.4 [SD 4.9] % versus 13.0 [SD 5.6] %). Cholesterol esters, unesterified cholesterol, and triglycerides were increased in plaques associated with symptoms (22.5 [SD 23.3] mg/g versus 13.3 [SD 3.2]; P=0.04), but no differences were detected between echolucent and echogenic plaques (13.5 [SD 4.0] versus 20.2 [SD 21.5] mg/g). Similar results were obtained by Oil Red O staining (symptomatic 7.6 [SD 4.7] % versus asymptomatic 4.2 [SD 3.6] %; P=0.03; echolucent 5.9 [SD 4.1] % versus echogenic 5.0 [SD 4.0] % of area). CONCLUSIONS: Echogenicity of carotid plaques is mainly determined by their elastin and calcium but not collagen or lipid content. In addition, echolucency is associated to higher elastin content.
Authors: Ronny X Li; Iason Z Apostolakis; Paul Kemper; Matthew D J McGarry; Ada Ip; Edward S Connolly; James F McKinsey; Elisa E Konofagou Journal: Ultrasound Med Biol Date: 2018-11-12 Impact factor: 2.998
Authors: Caroline Heijl; Fredrik Kahn; Andreas Edsfeldt; Christoffer Tengryd; Jan Nilsson; Isabel Goncalves Journal: Clin Med Insights Cardiol Date: 2020-08-25
Authors: Lars Lind; Jessika Andersson; Monika Rönn; Thomas Gustavsson; Peter Holdfelt; Johannes Hulthe; Anders Elmgren; Kersti Zilmer; Mihkel Zilmer Journal: Lipids Date: 2007-11-15 Impact factor: 1.880
Authors: Giuseppe Asciutto; Nuno V Dias; Andreas Edsfeldt; Mihaela Nitulescu; Ana Persson; Marie Nilsson; Pontus Dunér; Jan Nilsson; Isabel Gonçalves Journal: PLoS One Date: 2015-03-24 Impact factor: 3.240
Authors: Anouk L M Eikendal; Karlijn A Groenewegen; Michiel L Bots; Sanne A E Peters; Cuno S P M Uiterwaal; Hester M den Ruijter Journal: J Am Heart Assoc Date: 2016-05-12 Impact factor: 5.501
Authors: Isabel Gonçalves; Mihaela Nitulescu; Takaomi C Saido; Nuno Dias; Luis M Pedro; José Fernandes E Fernandes; Mikko P S Ares; Isabella Pörn-Ares Journal: BMC Cardiovasc Disord Date: 2009-06-18 Impact factor: 2.298